Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Controlled Trial of Sequential Chemotherapy and Radiotherapy Versus Concurrent Chemoradiotherapy in Adjuvant Treatment of Breast Cancer (CONCERT)

NCT06926543 is registered in ClinicalTrials.gov with Dr. Tabassum Wadasadawala as lead sponsor.

NCT NCT06926543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06926543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Controlled Trial of Sequential Chemotherapy and Radiotherapy Versus Concurrent Chemoradiotherapy in Adjuvant Treatment of Breast Cancer (CONCERT)
Lead sponsor
Dr. Tabassum Wadasadawala
Phase
Phase 3
Overall status
Recruiting
Start date
May 14, 2024
Completion date
May 31, 2031
Enrollment
858 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer, stage iib breast cancer, stage iii breast cancer